Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis and pain.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
Medication withdrawal in relapsing-remitting multiple sclerosis: why not?
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
Modifiable Comorbidities and Disability in Multiple Sclerosis.
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Balance control in multiple sclerosis: Correlations of trunk sway during stance and gait tests with disease severity.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
A rare case of mixed connective tissue disease complicated with neuromyelitis optica.
Value of NMO-IgG determination at the time of presentation as CIS.
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.
[Neuromyelitis optica spectrum disorder: a case report].
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Multiple sclerosis and oral health--an update.
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Role of adenosine in oligodendrocyte precursor maturation.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
Pages
« first
‹ previous
…
172
173
174
175
176
177
178
179
180
…
next ›
last »